ArticleInternational journal of retina and vitreous2025

Faricimab for treatment-resistant choroidal neovascularization (CNV) in neovascular age-related macular degeneration (nAMD): seven-months results using artificial intelligence and OCTA.

Anna Heinke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.